The invasive and tumor sphere-forming abilities of HNSCC cells, enhanced by TNS4 overexpression, were significantly attenuated upon treatment with the TGFβ signaling inhibitor LY2109761 (Figure 5C, 5D). The gene discussed is TGFB1; the disease is neoplasm.